Evidence map›Paper›PMID 30590092›Full record

ArticleExperimental hematology2019

MISTRG mice support engraftment and assessment of nonhuman primate hematopoietic stem and progenitor cells.

Stefan Radtke, Yan-Yi Chan, Trisha R Sippel, Hans-Peter Kiem, Anthony Rongvaux

Open access · greenAbstract read
In one paragraph

Article in Experimental hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Identification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Allogeneic and xenogeneic lymphoid reconstitution in aFrontiers in veterinary science · 2022
    Article
  12. Review
  13. Review
  14. Purification of Human CD34Molecular therapy. Methods & clinical development · 2020
    Article
  15. Article
  16. Mouse Tumor Models for Advanced Cancer Immunotherapy.International journal of molecular sciences · 2020
    Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stefan RadtkeProgram in Cell and Gene Therapy, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Yan-Yi ChanProgram in Cell and Gene Therapy, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Trisha R SippelProgram in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.
Hans-Peter KiemProgram in Cell and Gene Therapy, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Medicine, University of Washington School of Medicine, Seattle, WA; Department of Pathology, University of Washington School of Medicine, Seattle, WA. Electronic address: hkiem@fredhutch.org.
Anthony RongvauxProgram in Immunology, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Immunology, University of Washington School of Medicine, Seattle, WA. Electronic address: rongvaux@fredhutch.org.
Fred Hutch Cancer Center · USUniversity of Washington · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
ZFN-Modified Stem Cells for HIV EradicationU19AI096111 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER · 2011 to 2015
$20.8M
Interdisciplinary Tranining in Cancer ResearchT32CA080416 · NCI · UNIVERSITY OF WASHINGTON · PI STODDARD, BARRY L. · 1998 to 2023
$9.7M
Stem Cell and Transplantation BiologyU54DK106829 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DEREK L STIREWALT · 2015 to 2026
$9.1M
Evaluation of Pluripotent Stem Cell-Derived Blood Cells in Nonhuman Primate ModelR01HL115128 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER, RAFII, SHAHIN · 2013 to 2016
$3.3M
Development of safe and efficient gene therapy strategies for hemoglobinopathiesR01HL098489 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KIEM, HANS-PETER · 2010 to 2013
$2.8M
NCI NIH HHS P30 CA015704NCI NIH HHS T32 CA080416NHLBI NIH HHS R01 HL098489NHLBI NIH HHS R01 HL115128NIAID NIH HHS U19 AI096111NIDDK NIH HHS U54 DK106829
6 · The paper itself

Abstract

Preclinical feasibility, safety, and efficacy testing of hematopoietic stem cell (HSC)-mediated gene therapy approaches is commonly performed in large-animal models such as nonhuman primates (NHPs). Here, we wished to determine whether mouse models would allow engraftment of NHP HSPCs, which would enable more facile and less costly evaluation of promising strategies. In this study, we comprehensively tested two mouse strains for the engraftment of NHP CD34

Indexed as

Hematopoietic Stem CellsModels, BiologicalAnimalsGraft SurvivalHaplorhiniHematopoietic Stem Cell TransplantationHeterograftsMiceMice, TransgenicSpecies Specificity

Identifiers

PMID30590092
PMCPMC6719784
OpenAlexW2905863452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.